We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
(+2.7%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$65.3M |
| 2 |
Global Payments
GPN
|
+$40.3M |
| 3 |
Microsoft
MSFT
|
+$37.9M |
| 4 |
L3Harris
LHX
|
+$32.8M |
| 5 |
Amazon
AMZN
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$64.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$57.1M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$40M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$39.2M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Financials | 15.56% |
| 3 | Healthcare | 12.85% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Gaia
GAIA
$48.4M
| $123K | ﹤0.01% |
18,803
+1,412
| +8% | +$9.96K |
|
|
KALV
2852
DELISTED
KalVista Pharmaceuticals
KALV
| $123K | ﹤0.01% |
10,639
-80
| -0.7% | -$1.29K |
|
2853
Sutro Biopharma
STRO
$425M
| $123K | ﹤0.01% |
1,358
+116
| +9% | +$11.7K |
|
|
EVLO
2854
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $122K | ﹤0.01% |
1,002
+71
| +8% | +$9.76K |
|
|
ELVT
2855
DELISTED
Elevate Credit, Inc.
ELVT
| $121K | ﹤0.01% |
28,677
+702
| +3% | +$3.12K |
|
|
GEN
2856
DELISTED
Genesis Healthcare, Inc.
GEN
| $120K | ﹤0.01% |
107,996
-160
| -0.1% | -$185 |
|
2857
Marchex
MCHX
$83.3M
| $119K | ﹤0.01% |
37,895
+5,022
| +15% | +$19.3K |
|
|
CVIA
2858
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $119K | ﹤0.01% |
58,784
+5,314
| +10% | +$9.87K |
|
2859
Energous
WATT
$98.2M
| $116K | ﹤0.01% |
58
-1
| -2% | -$2.33K |
|
|
TYME
2860
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $116K | ﹤0.01% |
97,749
-1,352
| -1% | -$1.7K |
|
2861
Abeona Therapeutics
ABEO
$389M
| $115K | ﹤0.01% |
2,034
+168
| +9% | +$12.6K |
|
2862
Lee Enterprises
LEE
$181M
| $115K | ﹤0.01% |
5,653
+729
| +15% | +$14.9K |
|
2863
Nature's Sunshine
NATR
$360M
| $114K | ﹤0.01% |
13,715
+1,273
| +10% | +$11.6K |
|
|
VAPO
2864
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $113K | ﹤0.01% |
+1,487
| New | +$173K |
|
2865
Comscore
SCOR
$112M
| $112K | ﹤0.01% |
2,923
+307
| +12% | +$17.7K |
|
|
ZYXI
2866
DELISTED
Zynex
ZYXI
| $112K | ﹤0.01% |
12,903
| – | – |
|
2867
Marker Therapeutics
MRKR
$20.5M
| $111K | ﹤0.01% |
2,174
+106
| +5% | +$6.26K |
|
|
NOVA
2868
DELISTED
Sunnova Energy
NOVA
| $110K | ﹤0.01% |
+10,251
| New | +$111K |
|
|
CHMA
2869
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $110K | ﹤0.01% |
22,218
+2,265
| +11% | +$12.8K |
|
2870
Genie Energy
GNE
$368M
| $109K | ﹤0.01% |
14,600
+1,158
| +9% | +$10.1K |
|
2871
KALA BIO
KALA
$14.4M
| $109K | ﹤0.01% |
11
| – | – |
|
|
TCS
2872
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $108K | ﹤0.01% |
1,636
+151
| +10% | +$12.3K |
|
|
SBOW
2873
DELISTED
SilverBow Resources, Inc.
SBOW
| $108K | ﹤0.01% |
11,149
+870
| +8% | +$8.96K |
|
|
LOGC
2874
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $108K | ﹤0.01% |
10,000
-75
| -0.7% | -$802 |
|
2875
Savara
SVRA
$1.11B
| $107K | ﹤0.01% |
40,280
+395
| +1% | +$987 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
- RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
- RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
- RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
- RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.
Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.